Table 2 Baseline data of lung squamous cell carcinoma (LUSC) samples
From: GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
Characteristics | Number | Percent (%) |
|---|---|---|
Age | Â | Â |
≥ 65 | 355 | 54.5 |
< 65 | 186 | 33.8 |
NA | 9 | 1.6 |
Location | Â | Â |
Central Lung | 157 | 28.5 |
Peripheral Lung | 101 | 18.4 |
NA | 292 | 53.1 |
years_smoked | Â | Â |
≥ 53 | 177 | 32.2 |
< 53 | 287 | 52.2 |
NA | 86 | 15.6 |
pathologic_M | Â | Â |
M0 | 443 | 80.5 |
M1 | 6 | 1.1 |
M1a | 1 | 0.2 |
M1b | 1 | 0.2 |
MX | 94 | 17.1 |
NA | 5 | 0.9 |
pathologic_N | Â | Â |
N0 | 352 | 64.0 |
N1 | 143 | 26.0 |
N2 | 43 | 7.8 |
N3 | 5 | 0.9 |
NX | 7 | 1.3 |
pathologic_T | Â | Â |
T1 | 53 | 9.6 |
T1a | 26 | 4.7 |
T1b | 44 | 8.0 |
T2 | 187 | 34.0 |
T2a | 100 | 18.2 |
T2b | 40 | 7.3 |
T3 | 76 | 13.8 |
T4 | 24 | 4.4 |
radiation_therapy | Â | Â |
Yes | 51 | 9.3 |
No | 386 | 70.2 |
NA | 113 | 20.5 |
Gender | Â | Â |
Female | 144 | 26.2 |
Male | 406 | 73.8 |
tumor_stage | Â | Â |
I | 270 | 49.1 |
II | 179 | 32.5 |
III | 89 | 16.2 |
IV | 8 | 1.5 |
NA | 4 | 0.7 |
GPC3 Expression | Â | Â |
≥ 4.48 | 289 | 52.5 |
< 4.48 | 261 | 47.5 |